These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27280542)

  • 21. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study
    Levine LD; Downes KL; Romero JA; Pappas H; Elovitz MA
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3792-3800. PubMed ID: 29727248
    [No Abstract]   [Full Text] [Related]  

  • 22. Cervicovaginal fetal fibronectin concentrations: predictive value of impending birth in postterm pregnancies.
    Mouw RJ; Egberts J; Kragt H; van Roosmalen J
    Eur J Obstet Gynecol Reprod Biol; 1998 Sep; 80(1):67-70. PubMed ID: 9758262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of cervical electrical impedance spectroscopy to predict spontaneous preterm delivery in asymptomatic women: the ECCLIPPx prospective cohort study.
    Anumba DOC; Stern V; Healey JT; Dixon S; Brown BH
    Ultrasound Obstet Gynecol; 2021 Aug; 58(2):293-302. PubMed ID: 32798253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal fibronectin, cervical length, and the risk of preterm birth in patients with an ultrasound or physical exam indicated cervical cerclage.
    Kim RS; Gupta S; Lam-Rachlin J; Saltzman DH; Rebarber A; Fox NS
    J Matern Fetal Neonatal Med; 2016 Nov; 29(22):3602-5. PubMed ID: 26782923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting preterm delivery: comparison of cervicovaginal interleukin (IL)-1beta, IL-6 and IL-8 with fetal fibronectin and cervical dilatation.
    Coleman MA; Keelan JA; McCowan LM; Townend KM; Mitchell MD
    Eur J Obstet Gynecol Reprod Biol; 2001 Apr; 95(2):154-8. PubMed ID: 11301160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The preterm prediction study: quantitative fetal fibronectin values and the prediction of spontaneous preterm birth. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
    Goepfert AR; Goldenberg RL; Mercer B; Iams J; Meis P; Moawad A; Thom E; VanDorsten JP; Caritis SN; Thurnau G; Miodovnik M; Dombrowski M; Roberts JM; McNellis D
    Am J Obstet Gynecol; 2000 Dec; 183(6):1480-3. PubMed ID: 11120514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative fetal fibronectin for prediction of preterm birth in asymptomatic twin pregnancy.
    Kuhrt K; Hezelgrave-Elliott N; Stock SJ; Tribe R; Seed PT; Shennan AH
    Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1191-1197. PubMed ID: 32249408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women.
    Abbott DS; Radford SK; Seed PT; Tribe RM; Shennan AH
    Am J Obstet Gynecol; 2013 Feb; 208(2):122.e1-6. PubMed ID: 23164760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Preterm Prediction Study: sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
    Goldenberg RL; Iams JD; Das A; Mercer BM; Meis PJ; Moawad AH; Miodovnik M; VanDorsten JP; Caritis SN; Thurnau GR; Dombrowski MP; Roberts JM; McNellis D
    Am J Obstet Gynecol; 2000 Mar; 182(3):636-43. PubMed ID: 10739521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a tool incorporating cervical length and quantitative fetal fibronectin to predict spontaneous preterm birth in asymptomatic high-risk women.
    Kuhrt K; Smout E; Hezelgrave N; Seed PT; Carter J; Shennan AH
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):104-9. PubMed ID: 25846437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New biomarkers for the prediction of spontaneous preterm labour in symptomatic pregnant women: a comparison with fetal fibronectin.
    Liong S; Di Quinzio MK; Fleming G; Permezel M; Rice GE; Georgiou HM
    BJOG; 2015 Feb; 122(3):370-9. PubMed ID: 25056135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal fibronectin in patients at increased risk for premature birth.
    Nageotte MP; Casal D; Senyei AE
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):20-5. PubMed ID: 8296822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative fetal fibronectin screening in asymptomatic high-risk patients and the spectrum of risk for recurrent preterm delivery.
    Kurtzman J; Chandiramani M; Briley A; Poston L; Das A; Shennan A
    Am J Obstet Gynecol; 2009 Mar; 200(3):263.e1-6. PubMed ID: 19254585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.
    Ravi M; Beljorie M; El Masry K
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458
    [No Abstract]   [Full Text] [Related]  

  • 35. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador.
    Díaz J; Chedraui P; Hidalgo L; Medina M
    J Matern Fetal Neonatal Med; 2009 Feb; 22(2):89-93. PubMed ID: 19085632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Vandenbussche FP; Woiski MD; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; van der Post JA; Bossuyt PM; Opmeer BC; Kok M; Mol BW; van Baaren GJ
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intercellular adhesion molecule-1 (ICAM-1) in cervicovaginal fluid of women presenting with preterm labor: predictive value for preterm delivery.
    Marvin KW; Keelan JA; Coleman MA; McCowan LM; Zhou RL; Mitchell MD
    Am J Reprod Immunol; 2000 May; 43(5):264-71. PubMed ID: 10872605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women.
    Bruijn M; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers H; Spaanderman M; Bloemenkamp K; Haak MC; Bolte AC; Vandenbussche F; Woiski MD; Bax CJ; Cornette J; Duvekot JJ; Nij Bijvanck B; van Eyck J; Franssen M; Sollie KM; van der Post J; Bossuyt P; Opmeer BC; Kok M; Mol B; van Baaren GJ
    BJOG; 2016 Nov; 123(12):1965-1971. PubMed ID: 26667313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Will cervicovaginal interleukin-6 combined with fetal fibronectin testing improve the prediction of preterm delivery?
    LaShay N; Gilson G; Joffe G; Qualls C; Curet L
    J Matern Fetal Med; 2000; 9(6):336-41. PubMed ID: 11243290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of quantitative fetal fibronectin for spontaneous preterm birth in asymptomatic pregnancies: a systematic literature review and meta-analysis.
    Ruma MS; Betts M; Dodman S; Neupane B
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2279923. PubMed ID: 37953268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.